Germany will be the first European Union country to use experimental antibody therapy to cure former U.S. President Donald Trump, who was diagnosed in October last year, German health Minister Jens Spahn said today.
Jens Spahn told the German newspaper Bild am Sonntag: “The government is buying 200,000 doses for 400 million euros (about NT$13.6 billion).” Each dose is about 2,000 euros.
The so-called monoclonal antibody cocktail therapy will start being used in university hospitals in the coming week, Sparn said. He said Germany is the first country in the European Union to use the therapy against coronavirus disease 2019 (COVID-19).
Spahn did not reveal the manufacturer supplying the drugs, but confirmed it was the same as the one then-U.S. President Donald Trump took when he contracted the disease last October.
They work like a passive vaccination,” he said. Early use of these antibodies can help high-risk patients avoid getting even sicker.”
Trump was briefly hospitalized last year for his diagnosis and received REGN-COV2 antibody therapy developed by RegeneronPharmaceuticals Inc. before he was granted emergency use by regulatory authorities.
Trump later said the drug worked “very well”.
Recent Comments